Fed’s Hammack Says Bond Yield Surge Is Not Driven by Inflation Fears 
FDA Weighs Safety Standards for Psychedelic Therapies 
Dubai’s connectivity remains strong in an uncertain world 
Najib Razak Seeks Stay of 15-Year 1MDB Prison Sentence 
Judge Blocks Trump Rule Limiting Foreign Student Visas 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
Oil Prices Jump 3% as Houthi Attack Revives Supply Fears 
Trump Administration Prepares Sanctions Against Entire ICC 
US Supreme Court Revives Trump Administration Voter Citizenship Database 
Paramount Skydance Faces $30 Million Film Penalty in Warner Bros. Deal 
Rodrigo Duterte Makes First Public Appearance at ICC in 18 Months 
Japan Private-Sector Growth Slows as Domestic Demand Weakens 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Trump Signs Order to Cut Routine Childhood Vaccines 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
Add as a preferred source on Google
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
